The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.
Recent Posts
- Fed’s Powell cautions about higher long-term rates as ‘supply shocks’ provide policy challenges
- EToro IPO filing cites Israel-Hamas conflict as potential business risk
- Dick’s Sporting Goods to acquire Foot Locker for $2.4 billion in effort to corner Nike market
- Walmart CFO says price hikes from tariffs could start later this month, as retailer beats on earnings
- Key AI hub China restricts schoolchildren’s use of the tech